High materiality7/10
Summit Therapeutics price target lowered to $15 from $17 at Jefferies
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies cuts Summit Therapeutics (SMMT) price target to $15 from $17; current price around $13.68; priceChangeSinceSignal -0.15.
- Jefferies lowers target to $15 (from $17); price $13.68; change -0.15.
- Current price $13.68; target now $15; downgrade.
- Negative near-term bias after target cut by Jefferies.
Key facts
- 01
Target: $15
- 02
Posted price: $13.68
- 03
Analyst firm: Jefferies
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.